Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PRKDC | P78527 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ERN1 | O75460 | 7/20 | 0.44 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.41 |
| ▸ | ABAT | P80404 | 1/20 | 0.41 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14468256 | 0.83 | BACE1 (0.38) | CYP3A4KDM4EMAPTBACE1TSHR | |
| SCHEMBL16838212 | 0.78 | ALDH5A1 (0.59) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL1800032 | 0.78 | ERN1 (0.65) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL3894725 | 0.77 | TDP1 (0.60) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL371170 | 0.77 | TSHR (0.62) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL564611 | 0.77 | ATM (0.60) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL274241 | 0.77 | ERN1 (0.50) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL1014901 | 0.77 | BACE1 (0.63) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL40312 | 0.77 | MAPK1 (0.60) | CYP3A4KDM4EALDH1A1MAPTALOX15 | |
| SCHEMBL4941247 | 0.77 | CYP3A4 (0.47) | CYP3A4KDM4EALDH1A1MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143464-A | Method for preparing organic pigment easy to disperse in plastic | 江苏乾润新材料科技有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20110212048-A1 | POLYMALIC ACID-BASED MULTIFUNCTIONAL DRUG DELIVERY SYSTEM | CEDARS-SINAI MEDICAL CENTER (US) | 2011-09-01 | — | — | US | disclosed |
| US-7935677-B2 | Polymalic acid-based multi-functional drug delivery system | CEDARS-SINAI MEDICAL CENTER (US) | 2011-05-03 | — | — | US | disclosed |
| US-5783384-A | Selection of binding-molecules | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-07-21 | — | — | US | disclosed |
| WO-1996007676-A1 | POLYMERIC RESIN FOR DISULFIDE BOND SYNTHESIS | EKAGEN CORPORATION (US) | 1996-03-14 | — | — | WO | disclosed |
| EP-0623141-A1 | SELECTION OF BINDING-MOLECULES | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1994-11-09 | — | — | EP | disclosed |
| WO-1993014108-A1 | SELECTION OF BINDING-MOLECULES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212048-A1 | POLYMALIC ACID-BASED MULTIFUNCTIONAL DRUG DELIVERY SYSTEM | SLC43A1, HACD3, HACD2 | CYP3A4 3664/4885KDM4E 1687/4885ALDH1A1 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.